<div align="center">

# ğŸš€ `DisProtBench`:  Disorder-Aware, Task-Rich Benchmark for Evaluating Protein Structure Prediction in Realistic Biological Contexts

**Xinyue ZengÂ¹**, **Tuo WangÂ¹**, **Adithya KulkarniÂ¹**, **Alexander LuÂ¹**, **Alexandra NiÂ¹**, **Phoebe XingÂ¹**, **Junhan ZhaoÂ²Â³**, **Siwei Chenâ´âµ**, **Dawei ZhouÂ¹**

Â¹ Virginia Tech, Â² Harvard Medical School, Â³ Harvard T.H. Chan School of Public Health, â´ Broad Institute of MIT and Harvard, âµ Massachusetts General Hospital

<!-- Stylish Buttons -->
<p>
  <img src="Figures/Benchmark.png" alt="DisProtBench" width="90%">
</p>

</div>

---

## ğŸ“Œ Abstract
Recent advances in protein structure prediction have achieved near-atomic accuracy for well-folded proteins. However, current benchmarks inadequately assess model performance in biologically challenging contexts, especially those involving intrinsically disordered regions (IDRs), limiting their utility in applications like drug discovery, disease variant interpretation, and protein interface design. We introduce DisProtBench, a comprehensive benchmark for evaluating protein structure prediction models (PSPMs) under structural disorder and complex biological conditions. DisProtBench spans three key axes: 

(1) **Data complexity**â€”covering disordered regions, G protein-coupled receptors (GPCR)â€“ligand pairs, and multimeric complexes; 

(2) **Task diversity**â€”benchmarking twelve leading PSPMs across structure-based tasks with unified classification, regression, and interface metrics; 

(3) **Interpretability**â€”via the [DisProtBench Portal](http://zhoulab-1.cs.vt.edu:8501/), offering precomputed 3D structures and visual error analyses. 

Our results reveal significant variability in model robustness under disorder, with low-confidence regions linked to functional prediction failures. Notably, global accuracy metrics often fail to predict task performance in disordered settings, emphasizing the need for function-aware evaluation. DisProtBench establishes a reproducible, extensible, and biologically grounded framework for assessing next-generation PSPMs in realistic biomedical scenarios.

### ğŸ”¹ `DisProtBench` - A Unified Benchmark for IDR Investigation
We introduce DisProtBench with the following key contributions:

(1) **Database Development:** We curate a large benchmark dataset spanning biologically complex IDR scenarios, including thousands of disease-associated human proteins, GPCRâ€“ligand interactions, and multimeric complexes with disorder-mediated interfaces. It captures structural heterogeneity essential for assessing model robustness in realistic contexts.

(2) **Task and Toolbox Development:** We introduce a unified evaluation toolbox to benchmark eleven PSPMs on disorder-sensitive tasks, using consistent metrics across PPI prediction, ligand binding, and contact mapping. Incorporating pLDDT-based stratification, DisProtBench uniquely isolates model behavior in ambiguous regions across tasks and model families.

(3) **Visual-Interactive Interface Development:** The DisProtBench Portal provides 3D visualizations, model comparison heatmaps, and interactive results to explore structureâ€“function links, assess disorder-specific performance, and support hypothesis generationâ€”without local setup.

## ğŸ“‚ Datasets
We open-sourced our benchmark on [Kaggle](https://doi.org/10.34740/kaggle/ds/7400098), consisting of the following subsets:

| **Dataset**                  | **Description**                   | **# Number of Protein Only** | **Source**                                                                 |
|-----------------------------|-----------------------------------|---------------|---------------------------------------------------------------------------|
| **DisProt-Based Dataset**   | Disorder in human disease         | 3,060         | First proposed in our work                                                |
| **Protein Interaction Dataset** | Disorder-mediated interfaces      | 1,200         | [GitHub](https://github.com/ohuelab/SpatialPPI/tree/main)                |
| **Individual Protein Dataset** | Disorder and ligand binding       | 20            | [GitHub](https://github.com/ChengF-Lab/LISA-CPI?tab=readme-ov-file)       |
              
## ğŸ—ï¸ Toolbox
### ğŸ“‚ Models Toolbox
We benchmark state-of-the-art PSPMs spanning diverse architectures, inputs, and structural representations across protein-related tasks, as summarized below:

<div align="center">

| **PSPM**       | **Task**       | **Architecture**     | **Input**       | **Source**         | **Structural Representation**                |
|----------------|----------------|-----------------------|------------------|---------------------|------------------------|
| AF2            | PPI, Drug      | Evoformer             | MSA              | [Paper](https://www.nature.com/articles/s41586-021-03819-2)            | Atomic                 |
| AF3            | PPI, Drug      | Evoformer+LLM         | MSA + Seq        | [Paper](https://www.nature.com/articles/s41586-024-07487-w)            | Atomic + ligand        |
| OpenFold       | PPI, Drug      | Evoformer             | MSA              | [Paper](https://www.nature.com/articles/s41592-024-02272-z)               | Atomic                 |
| UniFold        | PPI, Drug      | Evoformer             | MSA              | [Paper](https://www.biorxiv.org/content/10.1101/2022.08.04.502811v3)        | Atomic                 |
| Boltz          | PPI, Drug      | Transformer           | Seq-only         | [Paper](https://www.biorxiv.org/content/10.1101/2024.11.19.624167v4)      | Coarse-grained         |
| Chai           | PPI, Drug      | Transformer           | Seq-only         | [Paper](https://www.biorxiv.org/content/10.1101/2024.10.10.615955v1)      | Coarse-grained         |
| Protenix       | PPI, Drug      | Transformer+          | Seq-only         | [Paper](https://www.biorxiv.org/content/10.1101/2025.01.08.631967v1)           | Atomic + ligand        |
| ESMFold        | Drug           | Transformer           | Seq-only         | [Paper](https://www.biorxiv.org/content/10.1101/2022.07.20.500902v3)             | Coarse-grained         |
| OmegaFold      | Drug           | Transformer           | Seq-only         | [Paper](https://www.biorxiv.org/content/10.1101/2022.07.21.500999v1)             | Coarse-grained         |
| RoseTTAFold    | Drug           | Hybrid (CNN+Attn)     | MSA              | [Paper](https://pubmed.ncbi.nlm.nih.gov/34282049/)           | Atomic                 |
| DeepFold       | Drug           | Custom DL             | Seq-only         | [Paper](https://pubmed.ncbi.nlm.nih.gov/37995286/)       | Atomic                 |
</div>

### ğŸ“Š Evaluation ToolBox
We evaluate model performance using a comprehensive set of classification, regression, and structural interface metrics, defined as follows:

<div align="center">
  
| **Metric**                         | **Definition / Formula**    | **Categorization**    | 
|-----------------------------------|---------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------|
| Precision (Positive Predictive Value) | TP / (TP + FP)     |  Classification Metrics        |
| Recall (Sensitivity)              | TP / (TP + FN)    |  Classification Metrics      |
| F1 Score                          | 2 Ã— TP / (2 Ã— TP + FP + FN)    |  Classification Metrics        |
| Accuracy                          | (TP + TN) / (TP + TN + FP + FN)    |  Classification Metrics        |
| Mean Absolute Error (MAE)         | $\displaystyle \frac{1}{N}\sum_{i=1}^{N}\lvert y_i-\hat{y}_i\rvert$   | Regression Metrics           |
| Mean Squared Error (MSE)          | $\displaystyle \frac{1}{N}\sum_{i=1}^{N}\bigl(y_i - \hat{y}_i\bigr)^2$   | Regression Metrics            |
| Pearson Correlation Coefficient (R) | Î£[(yáµ¢ âˆ’ È³)(Å·áµ¢ âˆ’ Å·Ì„)] / âˆš(Î£(yáµ¢ âˆ’ È³)Â² Ã— Î£(Å·áµ¢ âˆ’ Å·Ì„)Â²)| Regression Metrics           |
| Receptor Precision (RP)           | `size(True âˆ© Pred Receptor) / size(Pred Receptor)`  | Structural Interface Metrics  |     
| Receptor Recall (RR)              | `size(True âˆ© Pred Receptor) / size(True Receptor)`   | Structural Interface Metrics |     
| Ligand Precision (LP)             | `size(Pred Ligand âˆ© True Receptor) / size(Pred Ligand)`    | Structural Interface Metrics  |     
| Ligand Recall (LR)                | `size(True Ligand âˆ© Pred Receptor) / size(True Ligand)`  | Structural Interface Metrics |     
</div>

For the definitions of Receptor and Ligand, we follow the work of *Multi-level analysis of intrinsically disordered protein docking methods*:

<p align="center"> <img src="Figures/ligand_receptor.jpg" alt="Definition" width="80%"> </p>

## ğŸ¨ Visualize Portal
For more visualizations please link to 

ğŸ”— **Visual-Interactive Interface**: [DisProtBench](http://zhoulab-1.cs.vt.edu:8501/) 

<p align="center"> <img src="Figures/UI.png" alt="Visualization Examples" width="80%"> </p>

## ğŸ—ï¸ Results
### PPI Prediction
#### Generation Evaluation
The table below summarizes RR, RP, LR, and LP scores with 95% CI for each PSPM across three structural confidence thresholds (full sequence, pLDDT â‰¥ 30, and pLDDT â‰¥ 50), highlighting interface prediction performance under varying disorder levels:

|   | **Original**        |      |        |       | **pLDDT â‰¥ 30**        |      |     |         |**pLDDT â‰¥ 50**        |        |        |         |
|-------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|
| **PSPM**   | **RR**       | **RP**       | **LR**       | **LP**       | **RR**        | **RP**        | **LR**        | **LP**        | **RR**        | **RP**        | **LR**        | **LP**        |
| AF2         | 0.749 Â± 0.0217      | 0.7186 Â± 0.0226     | 0.7052 Â± 0.0215     | 0.7486 Â± 0.0215     | 0.7729 Â± 0.0208     | 0.7426 Â± 0.0217     | 0.7313 Â± 0.0207     | 0.7719 Â± 0.0204     | 0.7959 Â± 0.0197     | 0.7663 Â± 0.0207     | 0.7569 Â± 0.0198     | 0.7946 Â± 0.0193     |
| Boltz       | 0.7648 Â± 0.0155     | 0.7666 Â± 0.0153     | 0.7703 Â± 0.0155     | 0.7624 Â± 0.0140     | 0.7876 Â± 0.0147     | 0.7899 Â± 0.0146     | 0.7934 Â± 0.0148     | 0.7863 Â± 0.0142     | 0.8098 Â± 0.0139     | 0.8121 Â± 0.0138     | 0.8152 Â± 0.0140     | 0.8093 Â± 0.0134     |
| Chai        | 0.7583 Â± 0.0158     | 0.7746 Â± 0.0149     | 0.7674 Â± 0.0155     | 0.7571 Â± 0.0155     | 0.7815 Â± 0.0150     | 0.7980 Â± 0.0142     | 0.7898 Â± 0.0147     | 0.7804 Â± 0.0148     | 0.8034 Â± 0.0142     | 0.8203 Â± 0.0134     | 0.8117 Â± 0.0139     | 0.8029 Â± 0.0140     |
| OpenFold    | 0.6626 Â± 0.0271     | 0.6127 Â± 0.0312     | 0.6551 Â± 0.0274     | 0.6322 Â± 0.0280     | 0.6904 Â± 0.0263     | 0.6386 Â± 0.0306     | 0.6828 Â± 0.0267     | 0.6593 Â± 0.0272     | 0.7182 Â± 0.0254     | 0.6644 Â± 0.0297     | 0.7111 Â± 0.0258     | 0.6861 Â± 0.0263     |
| Proteinx    | 0.7344 Â± 0.0164     | 0.7427 Â± 0.0162     | 0.7385 Â± 0.0159     | 0.7310 Â± 0.0159     | 0.7584 Â± 0.0158     | 0.7658 Â± 0.0155     | 0.7626 Â± 0.0152     | 0.7544 Â± 0.0155     | 0.7811 Â± 0.0150     | 0.7884 Â± 0.0147     | 0.7857 Â± 0.0144     | 0.7775 Â± 0.0144     |
| UniFold     | 0.5876 Â± 0.0593     | 0.5431 Â± 0.0604     | 0.5892 Â± 0.0711     | 0.6116 Â± 0.0609     | 0.6127 Â± 0.0576     | 0.5671 Â± 0.0590     | 0.6172 Â± 0.0707     | 0.6384 Â± 0.0595     | 0.6386 Â± 0.0557     | 0.5923 Â± 0.0576     | 0.6426 Â± 0.0689     | 0.6655 Â± 0.0578     |

#### Prediction Evaluation
We use PPI prediction as a downstream task for evaluating PSPMs with the following pipeline:

<p align="center"> <img src="Figures/PPI.png" alt="PPI Pipeline" width="80%"> </p>

We examine the robustness of PSPMs in predicting PPI, a setting where disordered regions frequently mediate transient or flexible binding. The results are as follows:

<div align="center">
  
|          | **Original** |          |         |        | **pLDDT â‰¥ 30** |          |         |        | **pLDDT â‰¥ 50** |          |         |        |
| -------- | ------------ | -------- | ------- | ------ | -------------- | -------- | ------- | ------ | -------------- | -------- | ------- | ------ |
| **PSPM** | **Acc**      | **Prec** | **Rec** | **F1** | **Acc**        | **Prec** | **Rec** | **F1** | **Acc**        | **Prec** | **Rec** | **F1** |
| AF2      | 0.793        | 0.783    | 0.799   | 0.791  | 0.802          | 0.791    | 0.812   | 0.801  | 0.818          | 0.809    | 0.825   | 0.817  |
| AF3      | 0.900        | 0.888    | 0.915   | 0.901  | 0.905          | 0.893    | 0.905   | 0.906  | 0.913          | 0.899    | 0.930   | 0.914  |
| Boltz    | 0.850        | 0.848    | 0.853   | 0.850  | 0.858          | 0.853    | 0.863   | 0.858  | 0.869          | 0.870    | 0.868   | 0.869  |
| Chai     | 0.850        | 0.841    | 0.863   | 0.852  | 0.858          | 0.847    | 0.873   | 0.860  | 0.869          | 0.857    | 0.887   | 0.871  |
| OpenFold | 0.624        | 0.605    | 0.605   | 0.605  | 0.643          | 0.622    | 0.638   | 0.630  | 0.671          | 0.656    | 0.651   | 0.653  |
| Proteinx | 0.810        | 0.809    | 0.812   | 0.810  | 0.819          | 0.820    | 0.818   | 0.819  | 0.834          | 0.834    | 0.835   | 0.834  |
| UniFold  | 0.552        | 0.378    | 0.667   | 0.483  | 0.567          | 0.389    | 0.667   | 0.491  | 0.597          | 0.417    | 0.714   | 0.526  |
</div>

**Heatmaps** of -log10(p) values from McNemar tests comparing pairwise model performance on PPI prediction across different pLDDT thresholds. **Left**: full sequence; **Middle**: pLDDT â‰¥ 30; **Right**: pLDDT â‰¥ 50. Higher values indicate greater statistical significance between PSPMs. Blank blocks indicate self-comparisons, which are omitted by definition.

<p align="center"> <img src="Figures/overall_pvalue_heatmap_PPI.png" alt="PPI Heatmap" width="80%"> </p>

### Drug Discovery
#### Prediction Evaluation
We use drug discovery as a downstream task for evaluating PSPMs with the following pipeline:

<p align="center"> <img src="Figures/Drug.png" alt="Drug Discovery Pipeline" width="80%"> </p>

We examine the robustness of PSPMs in discovering drugs, a setting where disordered regions frequently mediate transient or flexible binding. The results are as follows:

<div align="center">
  
|             | **Original** |       | **pLDDT â‰¥ 30** |       | **pLDDT â‰¥ 50** |       |
| ----------- | ------------ | ----- | -------------- | ----- | -------------- | ----- |
| **Model**   | **MAE**      | **R** | **MAE**        | **R** | **MAE**        | **R** |
| AlphaFold3  | 0.048        | 0.999 | 0.048          | 0.999 | 0.049          | 0.999 |
| Proteinx    | 0.072        | 0.997 | 0.072          | 0.997 | 0.072          | 0.997 |
| Boltz       | 0.079        | 0.996 | 0.079          | 0.996 | 0.080          | 0.996 |
| Chai        | 0.096        | 0.995 | 0.096          | 0.995 | 0.097          | 0.995 |
| DeepFold    | 0.144        | 0.988 | 0.144          | 0.988 | 0.144          | 0.988 |
| ESMFold     | 0.150        | 0.987 | 0.150          | 0.987 | 0.151          | 0.987 |
| OmegaFold   | 0.151        | 0.987 | 0.151          | 0.987 | 0.152          | 0.987 |
| OpenFold    | 0.151        | 0.987 | 0.151          | 0.987 | 0.151          | 0.987 |
| AlphaFold2  | 0.160        | 0.985 | 0.160          | 0.985 | 0.160          | 0.985 |
| UniFold     | 0.183        | 0.981 | 0.183          | 0.981 | 0.184          | 0.981 |
| RoseTTAFold | 0.190        | 0.979 | 0.190          | 0.979 | 0.190          | 0.979 |
</div>

**Heatmaps** of -log10(p) values from Wilcoxon signed-rank tests comparing model performance in drug discovery tasks across different pLDDT thresholds. **Left**: full sequence; **Middle**: pLDDT â‰¥ 30; **Right**: pLDDT â‰¥ 50. Higher values indicate greater statistical significance in pairwise differences between PSPMs. Blank blocks indicate self-comparisons, which are omitted by definition.

<p align="center"> <img src="Figures/overall_pvalue_heatmap_Drug.png" alt="Drug Heatmap" width="80%"> </p>

## Folder Structure

```
DisProtBench/
â”‚
â”œâ”€â”€ Database/
â”‚   â”œâ”€â”€ DisProt-based Datase/         # Scripts for extracting and processing DisProt-based data
â”‚   â”œâ”€â”€ Protein Interaction Dataset/  # Main dataset files (e.g., dataset1200.json)
â”‚   â””â”€â”€ Individual Protein Datase/    # Scripts for individual protein data (e.g., GPCRs)
â”‚
â”œâ”€â”€ Downstream Evaluation/
â”‚   â”œâ”€â”€ toolbox/                      # Unified CLI and utility scripts for evaluation tasks
â”‚   â”œâ”€â”€ PPI/                          # PPI task scripts (preprocessing, training, testing)
â”‚   â””â”€â”€ CPI-drug discovery/           # CPI/drug discovery task scripts and AlphaFold tools
â”‚
â”œâ”€â”€ disprotbenchmark-metadata.json    # Metadata and dataset description
â”œâ”€â”€ LICENSE                          # Project license (MIT)
â””â”€â”€ README.md                        # This file
```

## Getting Started

### Prerequisites

- Python 3.7+
- [TensorFlow](https://www.tensorflow.org/) (for PPI tasks)
- [PyTorch](https://pytorch.org/) (for CPI tasks)
- [AlphaFold dependencies](https://github.com/deepmind/alphafold) (for structure-based tasks)
- Other dependencies: numpy, pandas, scikit-learn, tqdm, biopython, jax, etc.

For AlphaFold-related tasks, install dependencies from:
```
Downstream Evaluation/toolbox/cpi/alphafold/requirements.txt
```

Example (in a new environment):
```bash
pip install -r Downstream\ Evaluation/toolbox/cpi/alphafold/requirements.txt
```

### Installation

Clone the repository and install the required dependencies for your tasks of interest.

## Usage

### Unified CLI for Downstream Tasks

All major PPI and CPI tasks can be run from a single entry point:

```bash
cd Downstream\ Evaluation/toolbox
python toolbox.py <ppi|cpi> <subcommand> [options]
```

#### PPI Tasks

- **Train a PPI model:**
  ```bash
  python toolbox.py ppi train \
    --model DenseNet3D \
    --datapath ./data/example_dataset/distance \
    --train_set ./data/example_dataset/part_0_train.csv \
    --test_set ./data/example_dataset/part_0_val.csv \
    --savingPath ./models/example_model
  ```

- **Test a PPI model:**
  ```bash
  python toolbox.py ppi test \
    --model DenseNet3D \
    --datapath ./data/example_dataset/distance \
    --weights ./models/example_model/<timestamp>/best_model.weights.h5 \
    --output ./models/example_model/<timestamp>/preds.npy \
    --test_set ./data/example_dataset/part_0_test.csv
  ```

#### CPI/Drug Discovery Tasks

- **Prepare CPI dataset:**
  ```bash
  python toolbox.py cpi prepare_data --dataset data/original/top20_raw.csv --gpcr-col uniprot_id --smiles-col smiles --label-col pKi --file-name-col inchi_key --rep-path data/representations/top20/{}.npy --save-path data/ligands/top20/imgs --anno-path data/ligands/top20/anno -j 12 --test-size 0.3 --task regression
  ```

- **Train a CPI model:**
  ```bash
  python toolbox.py cpi train --cfg configs/train/top20.yml
  ```

- **Predict with a CPI model:**
  ```bash
  python toolbox.py cpi predict --cfg configs/prediction/pain.yml --data-dir data/pred/fda --rep-path data/representations/pain/P08908.npy --out-dir output/prediction/fda/P08908
  ```

#### Protein Structure Prediction

For generating protein structure, see the instructions of the models directly.

---

## License

This project is licensed under the MIT License. See the [LICENSE](LICENSE) file for details.

## References
- [LISA-CPI GitHub](https://github.com/ChengF-Lab/LISA-CPI?tab=readme-ov-file)
- [SpatialPPI GitHub](https://github.com/ohuelab/SpatialPPI/tree/main)
- [AlphaFold GitHub](https://github.com/deepmind/alphafold)
- [*Multi-level analysis of intrinsically disordered protein docking methods*](https://pubmed.ncbi.nlm.nih.gov/35609776/)
